Lionco Pharmaceutical Group Co.,Ltd. (603669.SS) SHH

Currency In CNY

AD

Valuation

Market Cap3.21B
Enterprise Value3.37B
P/E Ratio-22.67
PEG Ratio0.27
Price/Sales Ratio11.04
Price/Book Ratio6.28
Enterprise/Revenue11.61
Enterprise/EBITDA-33.05

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.48
Operating Margin-0.34
AD

Management Effectiveness

Return On Assets-0.15
Return On Equity-0.25

Income Statement

Revenue322.12M
Revenue/Share0.51
Gross Profit109.79M
EBITDA-94.53M
Net Income-193.24M
Diluted EPS-0.27

Balance Sheet

Total Cash156.84M
Total Cash/Share0.22
Total Debt347M
Total Debt/Equity0.56
Current Ratio1.15
Book Value Per Share0.89

Price History

52-Week Change9.45
52-Week High7.05
52-Week Low4.01
Moving Average 50 Days4.45
Moving Average 200 Days4.87

Statistics

Average Volume19.08M
Shares Outstanding712.33M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0
Last Split Factor7:5
Last Split DateMay 26, 2020
AD